Summary of project PR001090
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001090. The data can be accessed directly via it's Project DOI: 10.21228/M8T12F This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
| Project ID: | PR001090 |
| Project DOI: | doi: 10.21228/M8T12F |
| Project Title: | Sclerostin antibody increases trabecular bone and bone mechanical properties by increasing osteoblast activity damaged by whole-body irradiation in mice |
| Project Type: | Proteomics and Lipidomics basic research |
| Project Summary: | A mouse model study to test the hypothesis that treatment with anti-sclerostin antibody (Scl-Ab) would attenuate the adverse effects of irradiation by increasing bone volume and decreasing BM adipose tissue (BMAT), resulting in better quality bone. |
| Institute: | Mainehealth |
| Last Name: | Vary |
| First Name: | Calvin |
| Address: | 81 Research Drive, Scarborough, ME, USA 04074 |
| Email: | varyc@mmc.org |
| Phone: | 2073968148 |
| Funding Source: | NIH |
Summary of all studies in project PR001090
| Study ID | Study Title | Species | Institute | Analysis(* : Contains Untargted data) | Release Date | Version | Samples | Download(* : Contains raw data) |
|---|---|---|---|---|---|---|---|---|
| ST001704 | Sclerostin antibody increases trabecular bone and bone mechanical properties by increasing osteoblast activity damaged by whole-body irradiation in mice | Mus musculus | Mainehealth | MS* | 2021-03-01 | 1 | 96 | Uploaded data (141.6M)* |
